Star Imaging And Path Lab Stock Screener | Share Price & Fundamental Analysis
STARIMAGIN
Healthcare Service Provider
Track Star Imaging And Path Lab share price live with TickJournal's free stock screener.
Browse Star Imaging And Path Lab financial data to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Star Imaging And Path Lab Market Cap
₹99.28 Cr.
STARIMAGIN P/E Ratio (TTM)
-
Star Imaging And Path Lab P/B Ratio
1.02
EPS (TTM)
₹11.80
Dividend Yield
-
Debt to Equity
0.81
STARIMAGIN 52 Week High
-
Star Imaging And Path Lab 52 Week Low
-
Operating Margin
-
Profit Margin
-
STARIMAGIN Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹98.00
Total Equity
₹47.00
Star Imaging And Path Lab Share Price History - Stock Screener Chart
Screen STARIMAGIN historical share price movements with interactive charts. Analyze price trends and patterns.
Star Imaging And Path Lab Company Profile - Fundamental Screener
Screen Star Imaging And Path Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for STARIMAGIN shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE0YG001013
Star Imaging And Path Lab Balance Sheet Screener
Screen STARIMAGIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 98 | 82 | 61 | 58 |
| Current Assets | 67 | 53 | 26 | 32 |
| Fixed Assets | 21 | 22 | 19 | 15 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 17 | 18 | 16 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 47 | 31 | 19 | 18 |
| Share Capital | 14 | 2 | 2 | 2 |
| Reserves & Surplus | 34 | 30 | 17 | 17 |
Star Imaging And Path Lab Income Statement Screener - Profit & Revenue Analysis
Screen Star Imaging And Path Lab income statement and profit fundamentals.
Analyze STARIMAGIN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Star Imaging And Path Lab share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Revenue | 0 | 84 | 80 | 59 | 69 |
| Expenses | 0 | 55 | 56 | 53 | 54 |
| EBITDA | 0 | 29 | 24 | 6 | 15 |
| Operating Profit % | 0.00% | 34.00% | 29.00% | 10.00% | 21.00% |
| Depreciation | 0 | 5 | 5 | 3 | 4 |
| Interest | 0 | 3 | 2 | 2 | 2 |
| Profit Before Tax | 0 | 21 | 16 | 1 | 9 |
| Tax | 0 | 6 | 4 | 0 | 3 |
| Net Profit | 0 | 16 | 13 | 1 | 6 |
| EPS | 0.00 | 11.80 | 82.78 | 3.89 | 41.95 |
Star Imaging And Path Lab Cash Flow Screener - Liquidity Fundamentals
Screen STARIMAGIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -6 | 18 | 5 | 14 |
| Investing Activities | -4 | -7 | -7 | -4 |
| Financing Activities | 0 | 2 | -5 | -7 |
| Net Cash Flow | -10 | 13 | -7 | 3 |
Star Imaging And Path Lab Shareholding Pattern Screener
See Star Imaging And Path Lab shareholding pattern with promoter, FII, and DII holdings.
Check Star Imaging And Path Lab promoter holding and ownership changes for STARIMAGIN on TickJournal.
| Item | 2025-Sept | 2025-Aug | 2025-Mar |
|---|---|---|---|
| Promoter Holding | 71.92% | 71.92% | 100.00% |
| FII Holding | 1.37% | 1.18% | 0.00% |
| DII Holding | 9.33% | 11.44% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.30% | 11.01% | 0.00% |
| Other Holding | 5.08% | 4.46% | 0.00% |
| Shareholder Count | 779 | 7 | 7 |
Star Imaging And Path Lab Share Dividend Screener - Share Yield Analysis
Check Star Imaging And Path Lab dividend history with payout and yield data.
View Star Imaging And Path Lab dividend details including ex-dates and amounts for STARIMAGIN stock.
Star Imaging And Path Lab Stock Index Membership
See which indices include Star Imaging And Path Lab stock.
Check STARIMAGIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Star Imaging And Path Lab Market Events Screener - Corporate Actions
Get Star Imaging And Path Lab corporate actions including splits, bonuses, and buybacks.
Check Star Imaging And Path Lab stock events that may affect STARIMAGIN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.33% |
Star Imaging And Path Lab Competitors Screener - Peer Comparison
Screen STARIMAGIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,119 | 44.08 | 2,555 | 11.28% | 492 | 53.95 |
| Vijaya Diagnostic Centre | 10,190 | 63.10 | 700 | 23.06% | 144 | 63.89 |
| Metropolis Healthcare | 9,586 | 57.32 | 1,346 | 10.64% | 146 | 55.51 |
| Thyrocare Technologies | 6,332 | 46.76 | 702 | 20.80% | 91 | 59.36 |
| Nephrocare Health Services | 5,795 | 78.04 | 770 | 33.97% | 67 | 60.45 |
| Krsnaa Diagnostics | 1,929 | 24.10 | 743 | 16.70% | 78 | 50.09 |
| Suraksha Diagnostic | 1,437 | 44.50 | 256 | 15.11% | 31 | 61.25 |
| One Global Service Provider | 1,142 | 18.72 | 148 | 134.60% | 19 | 50.98 |
| 3B BlackBio DX | 1,021 | 18.04 | 112 | 28.72% | 48 | 42.56 |
| Sastasundar Ventures | 856 | 29.47 | 1,171 | -18.47% | -134 | 43.72 |
Star Imaging And Path Lab Company Announcements - News Screener
Screen STARIMAGIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-11 | Clarification On Price Movement Of Share | - |
| 2026-04-11 | Clarification sought from Star Imaging And Path Lab Ltd | - |
| 2026-04-10 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Opening Of New Diagnostic Centre At Dwarka New Delhi | - |
| 2026-04-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-09 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Empanelment With Bureau Of Indian Standards (BIS) And Indraprastha Power Generation Company Limited (IPGCL) | - |
| 2026-01-22 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Empanelment With National Institute Of Educational Planning And Administration (NIEPA) | - |
| 2026-01-21 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Empanelment With Indian National Science Academy (INSA) | - |
| 2026-01-21 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Acceptance Of Request For Providing Credit/Cashless Medical Services To All Serving Officer(S)/Official(S) Of The High Court Of Delhi | - |
| 2026-01-14 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Central Electricity Regulatory Commission (CERC) | - |
| 2026-01-13 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Indian Council Of Social Science Research (ICSSR) | - |
| 2026-01-07 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Acceptance Of Request For Providing Credit/Cashless Medical Services To All Serving Officer(S)/Official(S) Of The Supreme Court Of India | - |
| 2026-01-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-02 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Empanelment With WDRA Government Of India | - |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2025-11-13 | Unaudited (Standalone And Consolidated) Financial Results Of The Company For Half Year Ended 30Th September 2025 | - |
| 2025-11-13 | Board Meeting Outcome for Unaudited Financial Result (Standalone And Consolidated) For Half Year Ended 30Th September 2025 | - |
| 2025-11-12 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2025-11-11 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2025-11-04 | Board Meeting Intimation for To Consider And Approve Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Half Year Ended September 30 2025 | - |